The role of carbohydrates in the lipopolysaccharide (LPS)/toll-like receptor 4 (TLR4) Signalling

International Journal of Molecular Sciences

Volumn 18, Issue 11, 2017, Pages

  Cochet, Florent ^a   Peri, Francesco ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Kdo (3 deoxy d manno octulosonic acid); Lipopolysaccharide; MD 2 (myeloid differentiation factor 2); TLR4 (toll like receptor 4)

Indexed keywords

3 DEOXY MANNO OCTULOSONIC ACID; AMINOSUGAR; BIOLOGICAL FACTOR; CARBOHYDRATE; CD14 ANTIGEN; ETHANOLAMINE; LIPID A; LIPID BINDING PROTEIN; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 2; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; PROTEIN MD 2;

BIOLOGICAL ACTIVITY; CAMPYLOBACTER JEJUNI; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE MUTATION; HUMAN; INFLAMMATION; INNATE IMMUNITY; NEISSERIA MENINGITIDIS; NONHUMAN; PHYSICAL CHEMISTRY; PROTEIN INTERACTION; REVIEW; RHODOBACTER CAPSULATUS; RHODOBACTER SPHAEROIDES; SALMONELLA; STRUCTURE ACTIVITY RELATION; TLR SIGNALING; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BACTERIAL INFECTION; BACTERIUM; CHEMISTRY; IMMUNOLOGY; MICROBIOLOGY; MOLECULAR MODEL; SIGNAL TRANSDUCTION;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; HUMANS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; MODELS, MOLECULAR; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 85033573820     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18112318     Document Type: Review

References (108)

1. Janeway, C.A.; Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20, 197-216.
2. Takeuchi, O.; Akira, S. Pattern Recognition Receptors and Inflammation. Cell 2010, 140, 805-820.
3. Chen, G.; Shaw, M.H.; Kim, Y.-G.; Nuñez, G. NOD-Like Receptors: Role in Innate Immunity and Inflammatory Disease. Annu. Rev. Pathol. 2009, 4, 365-398.
4. Song, D.H.; Lee, J.-O. Sensing of microbial molecular patterns by Toll-like receptors. Immunol. Rev. 2012, 250, 216-229.
5. Kieser, K.J.; Kagan, J.C. Multi-receptor detection of individual bacterial products by the innate immune system. Nat. Rev. Immunol. 2017, 17, 376-390.
6. Imoto, M.; Yoshimura, H.; Sakaguchi, N.; Kusumoto, S.; Shiba, T. Total synthesis of lipid A. Tetrahedron Lett. 1985, 26, 1545-1548.
7. Yoshizaki, H.; Fukuda, N.; Sato, K.; Oikawa, M.; Fukase, K.; Suda, Y.; Kusumoto, S. First Total Synthesis of the Re-Type Lipopolysaccharide. Angew. Chem. Int. Ed. 2001, 40, 1475-1480.
8. Uehara, A.; Fujimoto, Y.; Kawasaki, A.; Kusumoto, S.; Fukase, K.; Takada, H. Meso-Diaminopimelic Acid and Meso-Lanthionine, Amino Acids Specific to Bacterial Peptidoglycans, Activate Human Epithelial Cells through NOD1. J. Immunol. 2006, 177, 1796-1804.
9. Homma, J.Y.; Matsuura, M.; Kanegasaki, S.; Kawakubo, Y.; Kojima, Y.; Shibukawa, N.; Kumazawa, Y.; Yamamoto, A.; Tanamoto, K.; Yasuda, T.; et al. Structural Requirements of Lipid A Responsible for the Functions: A Study with Chemically Synthesized Lipid A and Its Analogues. J. Biochem. 1985, 98, 395-406.
10. Huber, M.; Kalis, C.; Keck, S.; Jiang, Z.; Georgel, P.; Du, X.; Shamel, L.; Sovath, S.; Mudd, S.; Beutler, B.; et al. R-form LPS, the master key to the activation of TLR4/MD-2-positive cells. Eur. J. Immunol. 2006, 36, 701-711.
11. Akira, S.; Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4, 499-511.
12. Yang, J.; Zhao, Y.; Shao, F. Non-canonical activation of inflammatory caspases by cytosolic LPS in innate immunity. Curr. Opin. Immunol. 2015, 32, 78-83.
13. Gutsmann, T.; Schromm, A.B.; Brandenburg, K. The physicochemistry of endotoxins in relation to bioactivity. Int. J. Med. Microbiol. 2007, 297, 341-352.
14. Takayama, K.; Din, Z.Z.; Mukerjee, P.; Cooke, P.H.; Kirkland, T.N. Physicochemical properties of the lipopolysaccharide unit that activisit. J. Biol. Chem. 1990, 265, 14023-14029.
15. Takayama, K.; Mitchell, D.H.; Din, Z.Z.; Mukerjee, P.; Li, C.; Coleman, D.L. Monomeric Re lipopolysaccharide from Escherichia coli is more active than the aggregated form in the Limulus amebocyte lysate assay and in inducing Egr-1 mRNA in murine peritoneal macrophages. J. Biol. Chem. 1994, 269, 2241-2244.
16. Yu, L.; Tan, M.; Ho, B.; Ding, J.L.; Wohland, T. Determination of critical micelle concentrations and aggregation numbers by fluorescence correlation spectroscopy: Aggregation of a lipopolysaccharide. Anal. Chim. Acta 2006, 556, 216-225.
17. Giardina, P.C.; Gioannini, T.; Buscher, B.A.; Zaleski, A.; Zheng, D.S.; Stoll, L.; Teghanemt, A.; Apicella, M.A.; Weiss, J. Construction of Acetate Auxotrophs of Neisseria meningitidis to Study Host-Meningococcal Endotoxin Interactions. J. Biol. Chem. 2001, 276, 5883-5891.
18. Iovine, N.; Eastvold, J.; Elsbach, P.; Weiss, J.P.; Gioannini, T.L. The carboxyl-terminal domain of closely related endotoxin-binding proteins determines the target of protein-lipopolysaccharide complexes. J. Biol. Chem. 2002, 277, 7970-7978.
19. Post, D.M.B.; Zhang, D.; Eastvold, J.S.; Teghanemt, A.; Gibson, B.W.; Weiss, J.P. Biochemical and functional characterization of membrane blebs purified from Neisseria meningitidis serogroup B. J. Biol. Chem. 2005, 280, 38383-38394.
20. Schromm, A.B.; Brandenburg, K.; Rietschel, E.T.; Flad, H.D.; Carroll, S.F.; Seydel, U. Lipopolysaccharidebinding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes. FEBS Lett. 1996, 399, 267-271.
21. Schumann, R.R. Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: A short review. Res. Immunol. 1992, 143, 11-15.
22. Park, B.S.; Song, D.H.; Kim, H.M.; Choi, B.-S.; Lee, H.; Lee, J.-O. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009, 458, 1191-1195.
23. Wright, S.D.; Ramos, R.A.; Tobias, P.S.; Ulevitch, R.J.; Mathison, J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249, 1431-1433.
24. Ulevitch, R.J.; Tobias, P.S. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 1999, 11, 19-22.
25. Jiang, Q.; Akashi, S.; Miyake, K.; Petty, H.R. Cutting Edge: Lipopolysaccharide Induces Physical Proximity Between CD14 and Toll-Like Receptor 4 (TLR4) Prior to Nuclear Translocation of NF-κB. J. Immunol. 2000, 165, 3541-3544.
26. Gioannini, T.L.; Teghanemt, A.; Zhang, D.; Coussens, N.P.; Dockstader, W.; Ramaswamy, S.; Weiss, J.P. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc. Natl. Acad. Sci. USA 2004, 101, 4186-4191.
27. Teghanemt, A.; Prohinar, P.; Gioannini, T.L.; Weiss, J.P. Transfer of monomeric endotoxin from MD-2 to CD14: Characterization and functional consequences. J. Biol. Chem. 2007, 282, 36250-36256.
28. Deguine, J.; Barton, G.M. MyD88: A central player in innate immune signaling. F1000Prime Rep. 2014, 6, 97.
29. Kagan, J.C.; Su, T.; Horng, T.; Chow, A.; Akira, S.; Medzhitov, R. TRAM couples endocytosis of TLR4 to the induction of interferon beta. Nat. Immunol. 2008, 9, 361-368.
30. Fitzgerald, K.A.; Rowe, D.C.; Barnes, B.J.; Caffrey, D.R.; Visintin, A.; Latz, E.; Monks, B.; Pitha, P.M.; Golenbock, D.T. LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF. J. Exp. Med. 2003, 198, 1043-1055.
31. Brieger, A.; Rink, L.; Haase, H. Differential Regulation of TLR-Dependent MyD88 and TRIF Signaling Pathways by Free Zinc Ions. J. Immunol. 2013, 191, 1808-1817.
32. Zanoni, I.; Granucci, F. Role of CD14 in host protection against infections and in metabolism regulation. Front. Cell. Infect. Microbiol. 2013, 3, 32.
33. Mogensen, T.H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 2009, 22, 240-273.
34. Mata-Haro, V.; Cekic, C.; Martin, M.; Chilton, P.M.; Casella, C.R.; Mitchell, T.C. The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4. Science 2007, 316, 1628-1632.
35. Johnson, D. A Synthetic TLR4-active glycolipids as vaccine adjuvants and stand-alone immunotherapeutics. Curr. Top. Med. Chem. 2008, 8, 64-79.
36. Scior, T.; Alexander, C.; Zaehringer, U. Reviewing and identifying amino acids of human, murine, canine and equine TLR4/MD-2 receptor complexes conferring endotoxic innate immunity activation by LPS/lipid A, or antagonistic effects by Eritoran, in contrast to species-dependent modulation. Comput. Struct. Biotechnol. J. 2013, 5.
37. Seeley, J.J.; Ghosh, S. Molecular mechanisms of innate memory and tolerance to LPS. J. Leukoc. Biol. 2017, 101, 107-119.
38. Shiozaki, M.; Doi, H.; Tanaka, D.; Shimozato, T.; Kurakata, S.I. Syntheses of glucose analogues of E5564 as a highly potent anti-sepsis drug candidate. Bioorg. Med. Chem. 2006, 14, 3011-3016.
39. Gaekwad, J.; Zhang, Y.; Zhang, W.; Reeves, J.; Wolfert, M.A.; Boons, G.J. Differential induction of innate immune responses by synthetic lipid a derivatives. J. Biol. Chem. 2010, 285, 29375-29386.
40. Moran, A.P. Biological and serological characterization of Campylobacter jejuni lipopolysaccharides with deviating core and lipid A structures. FEMS Immunol. Med. Microbiol. 1995, 11, 121-130.
41. Di Lorenzo, F.; Billod, J.-M.; Martín-Santamaría, S.; Silipo, A.; Molinaro, A. Gram-Negative Extremophile Lipopolysaccharides: Promising Source of Inspiration for a New Generation of Endotoxin Antagonists. Eur. J. Org. Chem. 2017, 2017, 4055-4073.
42. Kusumoto, S.; Fukase, K.; Fukase, Y.; Kataoka, M.; Yoshizaki, H.; Sato, K.; Oikawa, M.; Suda, Y. Structural basis for endotoxic and antagonistic activities: Investigation with novel synthetic lipid A analogs. J. Endotoxin Res. 2003, 9, 361-366.
43. Tamai, R.; Asai, Y.; Hashimoto, M.; Fukase, K.; Kusumoto, S.; Ishida, H.; Kiso, M.; Ogawa, T. Cell activation by monosaccharide lipid A analogues utilizing Toll-like receptor 4. Immunology 2003, 110, 66-72.
44. Cighetti, R.; Ciaramelli, C.; Sestito, S.E.; Zanoni, I.; Kubik, Ł; Ardá-Freire, A.; Calabrese, V.; Granucci, F.; Jerala, R.; Martín-Santamaría, S.; et al. Modulation of CD14 and TLR4/MD-2 activities by a synthetic lipid A mimetic. ChemBioChem 2014, 15, 250-258.
45. Perrin-Cocon, L.; Aublin-Gex, A.; Sestito, S.E.; Shirey, K.A.; Patel, M.C.; André, P.; Blanco, J.C.; Vogel, S.N.; Peri, F.; Lotteau, V. TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection. Sci. Rep. 2017, 7, 40791.
46. Ciaramelli, C.; Calabrese, V.; Sestito, S.E.; Pérez-Regidor, L.; Klett, J.; Oblak, A.; Jerala, R.; Piazza, M.; Martín-Santamaría, S.; Peri, F. Glycolipid-based TLR4 modulators and fluorescent probes: Rational design, synthesis and biological properties. Chem. Biol. Drug Des. 2016, 88, 1-13.
47. Rodriguez Lavado, J.; Sestito, S.E.; Cighetti, R.; Aguilar Moncayo, E.M.; Oblak, A.; Lainšček, D.; Jiménez Blanco, J.L.; García Fernández, J.M.; Ortiz Mellet, C.; Jerala, R.; et al. Trehalose- and Glucose-Derived Glycoamphiphiles: Small-Molecule and Nanoparticle Toll-Like Receptor 4 (TLR4) Modulators. J. Med. Chem. 2014, 57, 9105-9123.
48. Fukase, Y.; Fujimoto, Y.; Adachi, Y.; Suda, Y.; Kusumoto, S.; Fukase, K. Synthesis of Rubrivivax gelatinosus lipid A and analogues for investigation of the structural basis for immunostimulating and inhibitory activities. Bull. Chem. Soc. Jpn. 2008, 81, 796-819.
49. Artner, D.; Oblak, A.; Ittig, S.; Garate, J.A.; Horvat, S.; Arrieumerlou, C.; Hofinger, A.; Oostenbrink, C.; Jerala, R.; Kosma, P.; et al. Conformationally constrained lipid a mimetics for exploration of structural basis of TLR4/MD-2 activation by lipopolysaccharide. ACS Chem. Biol. 2013, 8, 2423-2432.
50. Seydel, U.; Oikawa, M.; Fukase, K.; Kusumoto, S.; Brandenburg, K. Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity. Eur. J. Biochem. 2000, 267, 3032-3039.
51. Fort, M.M.; Mozaffarian, A.; Stover, A.G.; Correia, J.D.S.; Johnson, D.A.; Crane, R.T.; Ulevitch, R.J.; Persing, D.H.; Bielefeldt-Ohmann, H.; Probst, P.; et al. A Synthetic TLR4 Antagonist Has Anti-Inflammatory Effects in Two Murine Models of Inflammatory Bowel Disease. J. Immunol. 2005, 174, 6416-6423.
52. Billod, J.-M.; Lacetera, A.; Guzmán-Caldentey, J.; Martín-Santamaría, S. Computational Approaches to Toll-Like Receptor 4 Modulation. Molecules 2016, 21, 994.
53. Kawasaki, K.; Akashi, S.; Shimazu, R.; Yoshida, T.; Miyake, K.; Nishijima, M. Mouse Toll-like Receptor 4 MD-2 complex Mediates Lipopolysaccharide-mimetic Soìignal Transduction by Taxol. J. Biol. Chem. 2000, 275, 2251-2255.
54. Kawasaki, K.; Gomi, K.; Kawai, Y.; Shiozaki, M.; Nishijima, M. Molecular basis for lipopolysaccharide mimetic action of Taxol and flavolipin. J. Endotoxin Res. 2003, 9, 301-307.
55. Chan, M.; Hayashi, T.; Mathewson, R.D.; Nour, A.; Hayashi, Y.; Yao, S.; Tawatao, R.I.; Crain, B.; Tsigelny, I.F.; Kouznetsova, V.L.; et al. Identification of Substituted Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands. J. Med. Chem. 2013, 56, 4206-4223.
56. Nour, A.; Hayashi, T.; Chan, M.; Yao, S.; Tawatao, R.I.; Crain, B.; Tsigelny, I.F.; Kouznetsova, V.L.; Ahmadiiveli, A.; Messer, K.; et al. Bioorganic & Medicinal Chemistry Letters Discovery of substituted 4-aminoquinazolines as selective Toll-like receptor 4 ligands. Bioorg. Med. Chem. Lett. 2014, 24, 4931-4938.
57. Lien, E.; Chow, J.C.; Hawkins, L.D.; McGuinness, P.D.; Miyake, K.; Espevik, T.; Gusovsky, F.; Golenbock, D.T. A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/toll-like receptor 4 signaling pathway. J. Biol. Chem. 2001, 276, 1873-1880.
58. Morin, M.D.; Wang, Y.; Jones, B.T.; Su, L.; Surakattula, M.M.; Berger, M.; Huang, H.; Beutler, E.K.; Zhang, H.; Beutler, B.; et al. Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4(TLR4) Agonists. J. Med. Chem. 2016, 59, 4812-4830.
59. Wang, Y.; Su, L.; Morin, M.D.; Jones, B.T.; Whitby, L.R.; Surakattula, M.M.R.P.; Huang, H.; Shi, H.; Choi, J.H.; Wang, K.-W.; et al. TLR4/MD-2 activation by a synthetic agonist with no similarity to LPS. Proc. Natl. Acad. Sci. USA 2016, 113, 1695-1705.
60. Neve, J.E.; Wijesekera, H.P.; Du, S.; Jenkins, I.D.; Ripper, J.A.; Teague, S.J.; Campitelli, M.; Garavelas, A.; Nikolapoulos, G.; Le, P.V.; et al. Euodenine A: A Small-Molecule Agonist of Human TLR4. J. Med. Chem. 2014, 57, 1252-1275.
61. Peri, F.; Calabrese, V. Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: An update. J. Med. Chem. 2014, 57, 3612-3622.
62. Xie, N.; Gomes, F.P.; Deora, V.; Gregory, K.; Vithanage, T.; Nassar, Z.D.; Cabot, P.J.; Sturgess, D.; Shaw, P.N.; Parat, M.-O. Activation of mu-opioid receptor and Toll-like receptor 4 by plasma from morphine-treated mice. Brain Behav. Immun. 2017, 61, 244-258.
63. Shanmugam, A.; Rajoria, S.; George, A.L.; Mittelman, A.; Suriano, R.; Tiwari, R.K. Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants. PLoS ONE 2012, 7, e30839.
64. Ohto, U.; Fukase, K.; Miyake, K.; Shimizu, T. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc. Natl. Acad. Sci. USA 2012, 109, 7421-7426.
65. Yu, L.; Phillips, R.L.; Zhang, D.; Teghanemt, A.; Weiss, J.P.; Gioannini, T.L. NMR studies of hexaacylated endotoxin bound to wild-type and F126A mutant MD-2 and MD-2·TLR4 ectodomain complexes. J. Biol. Chem. 2012, 287, 16346-16355.
66. Oblak, A.; Jerala, R. The molecular mechanism of species-specific recognition of lipopolysaccharides by the MD-2/TLR4 receptor complex. Mol. Immunol. 2015, 63, 134-142.
67. Yoon, S.; Hong, M.; Han, G.W.; Wilson, I. A Crystal structure of soluble MD-1 and its interaction with lipid IVa. Proc. Natl. Acad. Sci. USA 2010, 107, 10990-10995.
68. Scior, T.; Lozano-Aponte, J.; Figueroa-Vazquez, V.; Yunes-Rojas, J.A.; Zähringer, U.; Alexander, C. Three-Dimensional Mapping of Differential Amino Acids of Human, Murine, Canine and Equine Tlr4/Md-2 Receptor Complexes Conferring Endotoxic Activation By Lipid a, Antagonism By Eritoran and Species-Dependent Activities of Lipid Iva in the Mammalian Lps Se. Comput. Struct. Biotechnol. J. 2013, 7, 1-11.
69. Kim, H.M.; Park, B.S.; Kim, J.I.; Kim, S.E.; Lee, J.; Oh, S.C.; Enkhbayar, P.; Matsushima, N.; Lee, H.; Yoo, O.J.; et al. Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran. Cell 2007, 130, 906-917.
70. Molinaro, A.; Holst, O.; Di, L.F.; Callaghan, M.; Nurisso, A.; D’Errico, G.; Zamyatina, A.; Peri, F.; Berisio, R.; Jerala, R.; et al. Chemistry of Lipid A: At the Heart of Innate Immunity. Chemistry 2015, 21, 500-519.
71. Peri, F.; Piazza, M. Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists. Biotechnol. Adv. 2012, 30, 251-260.
72. Hennessy, E.J.; Parker, A.E.; O’Neill, L.A.J. Targeting Toll-like receptors: Emerging therapeutics? Nat. Rev. Drug Discov. 2010, 9, 293-307.
73. Gay, N.J.; Gangloff, M. Structure and Function of Toll Receptors and Their Ligands. Annu. Rev. Biochem. 2007, 76, 141-165.
74. Tom, J.K.; Dotsey, E.Y.; Wong, H.Y.; Stutts, L.; Moore, T.; Davies, D.H.; Felgner, P.L.; Esser-Kahn, A.P. Modulation of Innate Immune Responses via Covalently Linked TLR Agonists. ACS Cent. Sci. 2015, 1, 439-448.
75. Huang, J.X.; Azad, M.A.K.; Yuriev, E.; Baker, M.A.; Nation, R.L.; Li, J.; Cooper, M.A.; Velkov, T. Molecular Characterization of Lipopolysaccharide Binding to Human α-1-Acid Glycoprotein. J. Lipids 2012, 2012, 1-15.
76. Knirel, Y.A.; Valvano, M.A. Bacterial Lipopolysaccharides; Springer: Berlin, Germany, 2011.
77. Bennett-guerrero, E.; Mcintosh, T.J.; Robin, G.; Snyder, D.S.; Gibbs, R.J.; Michael, G.; Poxton, I.R.; McIntosh, T.J.; Barclay, G.R.; Mythen, M.G.; et al. Preparation and Preclinical Evaluation of a Novel Liposomal Complete-Core Lipopolysaccharide Vaccine. Infect. Immun. 2000, 68, 6202-6208.
78. Di Padova, F.E.; Brade, H.; Barclay, G.R.; Poxton, L.R.; Liehl, E.; Schuetze, E.; Kocher, H.P.; Ramsay, G.; Schreier, M.H.; Mcclelland, D.B.L.; et al. A Broadly Cross-Protective Monoclonal Antibody Binding to Escherichia coli and Salmonella Lipopolysaccharides. Infect. Immun. 1993, 61, 3863-3872.
79. Luk, J.M.; Lind, S.M.; Tsang, R.S.; Lindberg, A.A. Epitope mapping of four monoclonal antibodies recognizing the hexose core domain of Salmonella lipopolysaccharide. J. Biol. Chem. 1991, 266, 23215-23225.
80. Galanos, C.; Luderitz, O.; Rietschel, E.T.; Westphal, O.; Brade, H.; Brade, L.; Freudenberg, M.; Schade, U.; Imoto, M.; Yoshimura, H.; et al. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur. J. Biochem. 1985, 148, 1-5.
81. Erridge, C.; Bennett-guerrero, E.; Poxton, I.R. Structure and function of lipopolysaccharides. Microbes Infect. 2002, 4, 837-851.
82. Muroi, M.; Tanamoto, K. The polysaccharide portion plays an indispensable role in Salmonella LPS-induced activation of NF-kB through human TLR-4. Infect. Immun. 2002, 70, 6043-6047.
83. Demchenko, A.V.; Wolfert, M.A.; Santhanam, B.; Moore, J.N.; Boons, G.J. Synthesis and biological evaluation of Rhizobium sin-1 lipid A derivatives. J. Am. Chem. Soc. 2003, 125, 6103-6112.
84. Zughaier, S.M.; Tzeng, Y.; Zimmer, S.M.; Carlson, R.W.; Stephens, D.S.; Datta, A. Neisseria meningitidis Lipooligosaccharide Structure-Dependent Activation of the Pathway Neisseria meningitidis Lipooligosaccharide Structure-Dependent Activation of the Macrophage CD14/Toll-Like Receptor 4 Pathway. Infect. Immun. 2004, 72, 371-380.
85. Zughaier, S.; Agrawal, S.; Stephens, D.S.; Pulendran, B. Hexa-acylation and KDO2-glycosylation determine the specific immunostimulatory activity of Neisseria meningitidis lipid a for human monocyte derived dendritic cells. Vaccine 2006, 24, 1291-1297.
86. Vasan, M.; Wolfert, M.A.; Boons, G.-J. Agonistic and antagonistic properties of a Rhizobium sin-1 lipid A modified by an ether-linked lipid. Org. Biomol. Chem. 2007, 5, 2087-2097.
87. Zhang, Y.; Wolfert, M.A.; Boons, G.J. The influence of the long chain fatty acid on the antagonistic activities of Rhizobium sin-1 lipid A. Bioorg. Med. Chem. 2007, 15, 4800-4812.
88. Zughaier, S.M.; Zimmer, S.M.; Datta, A.; Carlson, R.W.; Stephens, D.S. Differential Induction of the Toll-Like Receptor 4-MyD88-Dependent and-Independent Signaling Pathways by Endotoxins. Infect. Immun. 2005, 73, 2940-2950.
89. Raetz, C.R.; Garrett, T.A.; Reynolds, C.M.; Shaw, W.A.; Moore, J.D.; Smith, D.C.; Ribeiro, A.; Murphy, R.C.; Ulevitch, R.J.; Fearns, C.; et al. Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4. J. Lipid Res. 2006, 47, 1097-1111.
90. Lien, E.; Means, T.K.; Heine, H.; Yoshimura, A.; Kusumoto, S.; Fukase, K.; Fenton, M.J.; Oikawa, M.; Qureshi, N.; Monks, B.; et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Investig. 2000, 105, 497-504.
91. Raetz, C.R.; Whitfield, C. Lipopolysaccharide Endotoxins. Annu. Rev. Biochem. 2002, 71, 635-700.
92. Brabetz, W.; Müller-Loennies, S.; Holst, O.; Brade, H. Deletion of the heptosyltransferase genes rfaC and rfaF in Escherichia coli K-12 results in an Re-type lipopolysaccharide with a high degree of 2-aminoethanol phosphate substitution. Eur. J. Biochem. 1997, 247, 716-724.
93. Murphy, R.C.; Raetz, C.R.H.; Reynolds, C.M.; Barkley, R.M. Mass Spectrometry Advances in Lipidomica: Collision Induced Decomposition of Kdo2-Lipid A. Prostaglandins Other Lipid Mediat. 2005, 77, 131-140.
94. Rosner, M.R.; Tang, J.; Barzilay, I.; Khorana, H.G. Structure of the Lipopolysaccharide Mutant from an Escherichia coli Heptose-less Mutant. J. Biol. Chem. 1979, 254, 5906-5917.
95. Zhou, Z.; Lin, S.; Cotter, R.J.; Raetz, C.R.H. Lipid A Modifications Characteristic of Salmonella Typhimurium Are Induced by NH 4VO3 in Escherichia Coli K1. Biochemistry 1999, 274, 18503-18514.
96. Zhou, Z.; Ribeiro, A.A.; Lin, S.; Cotter, R.J.; Miller, S.I.; Raetz, C.R.H. Lipid A modifications in polymyxin-resistant Salmonella typhimurium. J. Biol. Chem. 2001, 276, 43111-43121.
97. Zhang, Y.; Gaekwad, J.; Wolfert, M.A.; Boons, G.J. Modulation of Innate Immune Responses with Synthetic Lipid A Derivatives. J. Am. Chem. Soc. 2007, 129, 5200-5216.
98. Zhang, Y.; Gaekwad, J.; Wolfert, M.A.; Boons, G.J. Innate immune responses of synthetic lipid a derivatives of Neisseria meningitidis. Chemistry 2008, 14, 558-569.
99. Mariathasan, S.; Weiss, D.S.; Newton, K.; McBride, J.; O’Rourke, K.; Roose-Girma, M.; Lee, W.P.; Weinrauch, Y.; Monack, D.M.; Dixit, V.M. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440, 228-232.
100. Roth, R.I.; Yamasaki, R.; Mandrell, R.E.; Griffiss, J.M. Ability of gonococcal and meningococcal lipooligosaccharides to clot Limulus amebocyte lysate. Infect. Immun. 1992, 60, 762-767.
101. Schromm, A.B.; Brandenburg, K.; Loppnow, H.; Zähringer, U.; Rietschel, E.T.; Carroll, S.F.; Koch, M.H.; Kusumoto, S.; Seydel, U. The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J. Immunol. 1998, 161, 5464-5471.
102. Vinh, T.; Adler, B.; Faine, S. Ultrastructure and chemical composition of lipopolysaccharide extracted from Leptospira interrogans serovar copenhageni. J. Gen. Microbiol. 1986, 132, 103-109.
103. Vinogradov, E.; Perry, M.B.; Conlan, J.W. Structural analysis of Francisella tularensis lipopolysaccharide. Eur. J. Biochem. 2002, 269, 6112-6118.
104. Petzold, M.; Thürmer, A.; Menzel, S.; Mouton, J.W.; Heuner, K.; Lück, C. A structural comparison of lipopolysaccharide biosynthesis loci of Legionella pneumophila serogroup 1 strains. BMC Microbiol. 2013, 13, 198.
105. Russa, R.; Urbanik-Sypniewska, T.; Choma, A.; Mayer, H. Identification of 3-deoxy-lyxo-2-heptulosaric acid in the core region of lipopolysaccharides from Rhizobiaceae. FEMS Microbiol. Lett. 1991, 68, 337-343.
106. Frecer, V.; Ho, B.; Ding, J.L. Interpretation of biological activity data of bacterial endotoxins by simple molecular models of mechanism of action. Eur. J. Biochem. 2000, 267, 837-852.
107. Liu, J. Use of Receptor-Based Drug Design and Applications in the Study of Finding Antagonists for MD-2/TLR4, GLP and CXCR4. Ph.D. Thesis, Faculty of the James T. Laney School of Graduate Studies of Emory University, Atlanta, GA, USA, 2012.
108. Henderson, J.C.; O’Brien, J.P.; Brodbelt, J.S.; Trent, M.S. Isolation and chemical characterization of lipid A from gram-negative bacteria. J. Vis. Exp. 2013, 966, e50623.